Neurotrophin receptors and selective loss of cholinergic neurons in Alzheimer disease

[1]  C. Dreyfus.  Effects of nerve growth factor on cholinergic brain neurons. , 1989, Trends in pharmacological sciences.

[2]  E. Mufson,et al.  Loss of nerve growth factor receptor-containing neurons in Alzheimer's disease: A quantitative analysis across subregions of the basal forebrain , 1989, Experimental Neurology.

[3]  D. Mash,et al.  Localization of nerve growth factor receptors in the normal human brain and in Alzheimer's disease , 1989, Neurobiology of Aging.

[4]  L. Hersh,et al.  Nerve growth factor receptor immunoreactive profiles in the normal, aged human basal forebrain: Colocalization with cholinergic neurons , 1989, The Journal of comparative neurology.

[5]  S. Lehéricy,et al.  Does loss of nerve growth factor receptors precede loss of cholinergic neurons in Alzheimer's disease? An autoradiographic study in the human striatum and basal forebrain , 1992, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[6]  S. Lehéricy,et al.  Selective loss of cholinergic neurons in the ventral striatum of patients with Alzheimer disease. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[7]  L. Butcher,et al.  Nerve growth factor receptor is associated with cholinergic neurons of the basal forebrain but not the pontomesencephalon , 1989, Neuroscience.

[8]  Y. Agid,et al.  Choline acetyltransferase activity and [ 3H]vesamicol binding in the temporal cortex of patients with Alzheimer's disease, Parkinson's disease, and rats with basal forebrain lesions , 1990, Neuroscience.

[9]  V. Chan‐Palay,et al.  Cholinergic Neurons of the Nucleus basalis Express Elevated Levels of Nerve Growth Factor Receptor mRNA in Senile Dementia of the Alzheimer Type , 1990 .

[10]  A. Fine,et al.  Nerve growth factor receptor mRNA distribution in human brain: normal levels in basal forebrain in Alzheimer's disease. , 1989, Brain research. Molecular brain research.

[11]  R. Houlgatte,et al.  Measurement of nerve growth factor-like immunoreactivity in human brain using an anti-mouse-NGF enzyme immunoassay , 1992, Neurochemistry International.

[12]  S. Lehéricy,et al.  Heterogeneity and selectivity of the degeneration of cholinergic neurons in the basal forebrain of patients with Alzheimer's disease , 1993, The Journal of comparative neurology.

[13]  Y. Agid,et al.  High affinity neurotrophin receptors in cholinergic neurons in the human brain. , 1994, Comptes rendus de l'Academie des sciences. Serie III, Sciences de la vie.

[14]  E. Hirsch,et al.  Differential vulnerability of cholinergic projections to the mediodorsal nucleus of the thalamus in senile dementia of Alzheimer type and progressive supranuclear palsy , 1991, Neuroscience.

[15]  S. Hunt,et al.  Nerve growth factor mRNA in peripheral and central rat tissues and in the human central nervous system: lesion effects in the rat brain and levels in Alzheimer's disease. , 1986, Brain research.

[16]  Y. Agid,et al.  Decreased choline acetyltransferase mRNA expression in the nucleus basalis of Meynert in Alzheimer disease: an in situ hybridization study. , 1992, Proceedings of the National Academy of Sciences of the United States of America.